The Russian pharmaceutical industry: Joint ventures and digital engagement?
We have previously looked at aspects of the drive to improve healthcare outcomes in Russia and considered channels such as telehealth, which are part of a wider governmental focus. Since 2005, $19 billion has been spent on improving the healthcare system and so far, various interventions and programmes have led to infant mortality being reduced by a [...]
Is failure an option?
No one wants to be wrong; ever. As much as there are trendy business mantras such as ‘Fail Fast’ which apparently encourage failure (as long as you learn quickly), it somehow just doesn’t translate to the world of a pharmaceutical company. In fact, ‘fail-fast’ is really an engineering concept that is most often considered in [...]
European physician engagement gets simpler
When it comes to targeting healthcare professionals, physician social networks provide a valuable resource for studying the behaviour of doctors, and engaging them in relevant and well-targeted ways. However, the sheer number of physician networks, and the range of capabilities, can make for complex strategy planning and implementation across international regions. Today, however, a brand [...]
Elite Global Forum: “Cultural change in a digital world”
Creation Healthcare’s Elite Global Forum was conceived to be a no-nonsense, no-limits, global think tank. Since that time, several informal discussions have been taking place around the globe in which professionals from pharmaceutical, hospital, government and not-for-profit organizations challenge each other, share ideas, and look to break new ground in healthcare engagement. While attending conferences [...]
Japanese Pharma places confidence in digital
A study by Creation Healthcare into engagement amongst pharmaceutical companies in Japan reveals a significant trend emerging towards digital channels and social media, in what has until now been a traditionally conservative environment. In partnership with Eyeforpharma, Creation Healthcare‘s research surveyed senior marketers, communicators and executives amongst the Japanese pharmaceutical and healthcare industry. The goal [...]
A Practical Guide to Interpreting PMCPA guidance
It was ironically only a couple of weeks ago that Creation Healthcare published a piece about “Healthcare engagement in the absence of regulatory guidance”. In that article, I made the point that “specific social media guidance cannot keep pace with change”, and more importantly that when using 3rd party engagement platforms like Facebook, Flickr or [...]
Engaging Key Opinion Leaders: A Strategic Approach
In the complex world of healthcare engagement, the role of key opinion leaders (KOLs) in influencing the behavior of healthcare professionals is becoming increasingly important. And as with any healthcare engagement strategy, there is more to working with key opinion leaders than simply adding another channel to the mix. Why consider KOLs? With so many [...]
“Shame on you” crisis leads to KV share price plummet
Less than three weeks after a Facebook page was set up by one patient angry with KV Pharmaceuticals’ pricing of its newly approved drug Makena, the US Food and Drug Administration (FDA) has today announced that KV should not have exclusive rights to produce similar products. This apparent about-turn resulted in the pharmaceutical company’s share [...]
Mobile: are you ready?
In essence, we are mobile and arguably much more today than ever before. And in the connected world in which we live, we want to have access to the same services during our “mobile day” that we do at work or at home. Devices such as the iPhone and the iPad opened new ways to [...]
“Shame on you”: an emerging pharma social media crisis
The launch of a Facebook page by pregnant mothers in the USA angry about KV Pharmaceuticals’ pricing of its newly FDA-approved synthetic progesterone product, Makena, raises once again the urgent need for pharmaceutical companies to plan ahead for social media engagement. Let’s take a brief look at the facts around this emerging PR crisis for [...]
European developments in online pharmacovigilance
A relatively new software company is challenging the landscape of social media monitoring, particularly in the pharmaceutical and healthcare industry.
Roche raises awareness of breast cancer in France through social media
October is international “Breast Cancer Awareness Month”; or “Octobre Rose” (“Pink October”) in France. This is an opportunity for patient groups, charities or states to raise awareness about breast cancer and reiterate the importance of screening. In France, more than 52,000 new breast cancer cases are estimated in 2010, making it the most common cancer [...]
Healthcare engagement for pharmaceutical communicators
When it comes to new channels of communication, it’s fair to say that the pharmaceutical industry is generally cautious. There are many reasons for this, including the complex regulatory framework within which pharma operates, and the potential size of penalties for failure to comply, as well as a difficult communications environment in which many pharmaceutical [...]
A medical information perspective on social media
For medical information professionals, the Internet presents an interesting dilemma. On the one hand, it is a chaotic environment; a dangerous place for a medical information professional. Yet on the other hand, it is difficult to ignore the testimonies of patients whose lives have literally been transformed through a wealth of health and medicine information, [...]
Can pharma enhance patient care through social media?
“This house believes patient care will be enhanced through pharma’s involvement in social media“. So read the title of the debate I was invited to take part in at the PIPA Annual Conference 2010 on 5th July. I was especially excited to take part in this debate, not only because of the opportunity to participate [...]
Eisai Co’s consumer-centric pharmaceutical website
In Japan’s highly conservative healthcare communications environment, some pharmaceutical companies are becoming world leaders in developing patient-focused corporate websites.
Japan: A pharmaceutical viewpoint
At the recent Marketing Excellence Japan 2010 conference, I caught up with some of the pharmaceutical company speakers and asked them about the unique aspects of pharmaceutical marketing in the Japanese healthcare environment.
Comparing the use of social media by Pharmaceuticals
Social media success and failure are closely linked to the level of engagement that you have with people. The engagement aspect is what shifts it from another form of broadcast media to a channel that can build trust, add value and make a difference to the people you serve.
Consumer health trends
In these slides, Paul Grant outlines how the Internet is changing healthcare by empowering the consumer and the e-patient. Paul looks at data and examples from the USA and Europe, and considers the impact of ratings websites, online health records, and the way in which doctors are responding to the e-patient.
EU healthcare communicators weigh-in on engagement
In this video, we capture experiences from some of the participants. Hear experts from Benenden Healthcare Society, Boehringer Ingelheim, Doctors.net.uk, Napp Pharmaceuticals, NHS Barking & Dagenham, Pfizer, and Systagenix and discover what healthcare engagement means to them.
Topics
Pharmaceuticals